Search

everythinglearnresearchcommunity

for

Search:↓

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oral contraceptives may cause hair loss in women.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.